Delsie Braganza

Delsie joined the Focal Point Research team in 2011 and has been an invaluable asset for our clients. With her strong regulatory and quality assurance background, she is able to help clients understand the Canadian and US requirements, set targets to achieve compliance, and attain their goals to get products to market.

Delsie is able to audit facilities, set up and maintain GMP compliant facilities, develop strong quality management systems, and co-ordinate successful Health Canada inspections. In addition to this, Delsie oversees all regulatory compliance reviews and submissions made to Health Canada and the US FDA.

Delsie obtained an Honours Bachelor of Science (Hons. B. Sc.) in Pharmaceutical Chemistry from the University of Toronto, Post-Graduate Certificate in Pharmaceutical Regulatory Affairs and Quality Operations (RAQ) from Seneca College and Regulatory Affairs Certification (RAC) from the Regulatory Affairs Professional Society (RAPS).

When she’s not learning something new, Delsie loves spending time with family, going on road trips or long walks, and swimming.

Articles

If you would like to be added to our newsletter, please send an email to mail@focalpointresearch.net with the subject line ‘Receive FPR Newsletter’.

Cosmetic Products Refused at Canadian Border Due to International Website Present on Label

Sep 7, 2018

Cosmetics Alliance has recently reported that there have been recent incidences of imported cosmetic products being held at the Canadian border, ultimately being turned back or destroyed at the border. This is due to the cosmetic product label referencing an...

Canada’s Cruelty-Free Cosmetics Act One Step Closer to Coming into Law

Sep 5, 2018

Just last month, the third reading of Bill S-214, the Cruelty-Free Cosmetics Act, had passed in the Senate. Bill S-214 is one of three animal protection bills that have been pushed through right before summer recess. The Cruelty-Free Cosmetics Act was first introduced...

Draft Screening Assessment Report for Benzophenone

Aug 29, 2018

Health Canada and Environment and Climate Change Canada have recently published their Draft Screening Assessment Report and Risk Management Scoping Document. These documents have evaluated benzophenone (also called diphenyl methanone) and its potential to harm...

Health Canada Warns Against Promotion of Cannabis at Events

Aug 22, 2018

Health Canada has recently sent out a statement regarding the growing number of medical cannabis producers licensed by the federal government who are engaging in promotional activities all around the country. This is particularly in regard to the promotion of cannabis...

U.S. Trade War Tariffs and the Impacts on the Cosmetic Industry

Aug 8, 2018

Over the past few months there have been a lot of news coming from the United States government relating to tariffs against many its trading partners. The many tariffs and retaliations by other nations interferes with a wide range of industries. Earlier this spring,...

Alpha-Hydroxy Acids and Acid Peel Products: Canadian Hotlist Confusion

Aug 1, 2018

Acid peel products have become increasingly popular in Canada. Acid peel products typically contain the Canadian Hotlist ingredients Alpha-Hydroxy-Acids (AHA’s). These peel products are intended for topical application only, are usually applied to the face, and can...

Amendments to Health Canada’s Cosmetic Ingredient Hotlist

Jul 27, 2018

Health Canada has recently updated their Cosmetic Ingredient Hotlist as of June 2018. This updated Hotlist has added pigment red 4, also known as Red 36 or CI 12085, to its list of restricted substances with a maximum concentration of 3% permitted in cosmetic...

Plastic Particles Are More Prevalent in Your Cosmetics & Personal Care Products Than You Think

Jul 20, 2018

Plastic microbeads are either banned or becoming banned in over 10 jurisdictions worldwide. However, this doesn’t mean that our cosmetics and personal care products are entirely plastic-free. There are many more plastic particles present that are in your everyday...

Health Canada Intends to Propose Post-Market Amendments to Medical Devices

Jul 18, 2018

Health Canada announced their plans to propose changes to strengthen the post-market surveillance and risk management of medical devices in Canada. This is part of the 5-year initiative on Health Canada’s regulatory review of drugs and devices as well as keeping in...

G7 Work to Reduce Plastic Waste through the Ocean Plastics Charter

Jul 13, 2018

There were a lot of topics discussed in the G7 summit in Ottawa last month. One major topic of conversation was related to ocean pollution and this has resulted in the newly formed Ocean Plastics Charter. This charter has been signed by leaders of Canada, France,...

« Older Entries

Next Entries »

“Focal Point Research has consistently and professionally looked after regulatory and quality issues of our brand for years. Through a courteous and knowledgeable team, they have managed to navigate us through an ever changing regulatory landscape while maintaining our interests, and allowed us to correctly distribute and sell within Canada.”

“I have truly enjoyed working with you over the last 8 years! You and your team have been an amazing resource for me. I have always been impressed by the knowledge and professionalism of everyone at Focal Point, which is a true testament to your leadership.”

Connect With Us

The Focal Point Research team is ready to help with all of your scientific and regulatory needs. Our team has the experience and expertise you need to see your product to market and we are eager to help you.

181 Lakeshore Road E. Mississauga, ON

1 (905) 271 2709

mail@focalpointresearch.net

Delsie Braganza

Jennifer Porter, BA Psychology, MBA – President & CEO

Articles

If you would like to be added to our newsletter, please send an email to mail@focalpointresearch.net with the subject line ‘Receive FPR Newsletter’.

Connect With Us